NCT03438812View on ClinicalTrials.gov

Dehydroepiandrosterone Maintain Mitochondrial Quality of Cumulus Cells in Poor Ovarian Responders

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 6, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Poor RespondersDehydroepiandrosterone
Interventions
DIETARY_SUPPLEMENT

dehydroepiandrosterone (DHEA)

Participants take DHEA 90 mg daily for two months at least before in vitro fertilization cycles.

Trial Locations (1)

81362

Kaohsiung Veterans General Hospital, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Veterans General Hospital.

OTHER

NCT03438812 - Dehydroepiandrosterone Maintain Mitochondrial Quality of Cumulus Cells in Poor Ovarian Responders | Biotech Hunter | Biotech Hunter